Short answer
Ingredients banned in Europe for food supplements fall into four groups: substances prohibited or restricted under Annex III of Regulation (EC) No 1925/2006 (for example ephedra, yohimbe and aloe-emodin are prohibited; monacolins from red yeast rice and green tea EGCG are capped), novel foods not yet authorised on the Union list (for example CBD), food additives removed from the EU list (titanium dioxide, E 171), and national bans. Poland has its own list in Dz.U. 2024 poz. 420, which includes DMAA, higenamine, hordenine, SARMs and kava. Check every ingredient against all four before you file a GIS notification.
Why US supplement ingredients are not allowed in the EU
In the US, a supplement ingredient is usually legal until the FDA acts against it. In the EU the logic runs the other way for many categories: some substances are listed as prohibited, new ingredients need prior authorisation, and additives must be on a positive list. We cover the wider differences between DSHEA and EU food law in our guide for US brands entering the EU. Here we stay with the ingredients.
Four separate mechanisms remove an ingredient from a Polish formula:
| Mechanism | Legal basis | What it does | Typical US ingredients caught |
|---|---|---|---|
| Annex III, Part A | Regulation (EC) No 1925/2006, Article 8 | Prohibits a substance in food | Ephedra, yohimbe, aloe-emodin and emodin |
| Annex III, Part B | Same | Allows a substance only under conditions, with label warnings | Red yeast rice, green tea extract |
| Novel food without authorisation | Regulation (EU) 2015/2283, Article 6(2) | Only authorised novel foods on the Union list may be sold | CBD, NMN |
| Food additive removed | Regulation (EU) 2022/63 | Deletes or limits an additive | Titanium dioxide (E 171) in coatings |
| National list | Dz.U. 2024 poz. 420 (Poland) | Bans named substances in all food, including supplements | DMAA, higenamine, hordenine, SARMs, MK-677 |
An ingredient can be clean under one mechanism and blocked under another. Run all four.
Substances restricted under Annex III: Parts A, B and C
Annex III of Regulation (EC) No 1925/2006 is the EU's list for "other substances" added to food. Its three parts are headed "Part A - Prohibited substances", "Part B - Restricted substances" and "Part C - Substances under Community scrutiny".
Article 8(2) explains the split. Where harmful effects are identified, the Commission puts the substance in Part A or Part B. Part C is used "if the possibility of harmful effects on health is identified but scientific uncertainty persists" (Regulation (EC) No 1925/2006, Article 8(2)). Part C is a waiting room, not a permission: "Within four years from the date a substance has been listed in Annex III, Part C," the Commission has to decide whether to allow it or move it to Part A or B (Article 8(5)).
Yohimbe shows how that ends. It sat in Part C; when "interested parties have not submitted any scientific data to the Authority" within the time limit, it was moved to Part A (Regulation (EU) 2019/650, recital 4). If your formula contains a Part C botanical today, plan as if it could become Part A within the life of your SKU.
Ingredients banned in Europe: the table
Each line below links to the act we read. Status is as of 29 October 2026; always open the consolidated Annex III on EUR-Lex before you finalise a formula.
| Ingredient (as sold in the US) | EU status | Source | For a Polish SKU |
|---|---|---|---|
| Ephedra (ma huang) | Part A, prohibited: "Ephedra herb and its preparations originating from Ephedra species" | Reg. (EU) 2015/403 | Remove |
| Yohimbe bark | Part A, prohibited: "Yohimbe bark and its preparations originating from Yohimbe (Pausinystalia yohimbe (K. Schum) Pierre ex Beille)" | Reg. (EU) 2019/650 | Remove. Poland also bans yohimbine hydrochloride and the yohimbine group |
| Aloe leaf "detox" and laxative blends | Part A: aloe-emodin, emodin, danthron and "preparations from the leaf of Aloe species containing hydroxyanthracene derivatives" | Reg. (EU) 2021/468 | Remove leaf preparations containing these derivatives |
| Senna, rhubarb root, cascara / frangula bark | Part C, under scrutiny: preparations containing hydroxyanthracene derivatives | Reg. (EU) 2021/468 | High risk. Plan a replacement |
| Red yeast rice | Part B: daily portion "shall provide less than 3 mg of monacolins from red yeast rice." | Reg. (EU) 2022/860 | Reformulate under 3 mg and add the mandatory warnings |
| Green tea extract (EGCG) | Part B: daily portion "shall contain less than 800 mg of (-)-epigallocatechin-3-gallate" | Reg. (EU) 2022/2340 | Reformulate under 800 mg and add the warnings |
| Titanium dioxide (E 171) in tablet or capsule coatings | Deleted from the Group II colours authorised at quantum satis; new footnote: "Titanium dioxide is not authorised in the food categories listed in Part D and E." Sell-off for older stock ran until 7 August 2022 | Reg. (EU) 2022/63 | Switch the coating or capsule colour |
| CBD | Novel food, not authorised | EFSA, 7 June 2022; AESAN, 12 February 2026 | Do not sell as food |
| NMN | Novel food; draft authorisation discussed in September 2026 | Czech consultation result; PAFF agenda, 25 September 2026 | Do not sell until it is on the Union list (to be confirmed at launch) |
| DMAA, higenamine, hordenine, SARMs, MK-677 (pre-workout and "sports" products) | Banned in Poland by national regulation | Dz.U. 2024 poz. 420 | Remove |
Restricted, not banned: red yeast rice and green tea extract
Part B substances stay legal, but the label has to carry fixed warnings. US labels almost never have them, so a sticker translation fails. For red yeast rice, Regulation (EU) 2022/860 requires, among others:
- "The label shall indicate the content of monacolins per portion of the product."
- A warning "not to consume a daily amount of 3 mg of monacolins from red yeast rice or more"
- "Should not be consumed by pregnant or lactating women, children below 18 years old and adults above 70 years old"
- "Should not be consumed if you are taking cholesterol-lowering medication"
- "Should not be consumed if you are already consuming other products containing red yeast rice"
For green tea extracts with EGCG, Regulation (EU) 2022/2340 requires the content of EGCG per portion, a warning not to consume 800 mg or more a day, and statements including "Should not be consumed on an empty stomach" and "Should not be consumed by pregnant or lactating women and children below 18 years old". The same act also lists green tea extracts containing EGCG in Part C, with an exclusion for aqueous extracts comparable to traditional green tea infusions, so the substance remains under review.
All of these warnings must appear in Polish on the pack. Plan the label space early; our Polish label guide covers the mandatory elements around them.
NMN EU status and CBD: novel food, not banned
NMN and CBD are often described online as "banned in Europe". Legally they are something else: novel foods without an authorisation, which means they cannot be sold as food until the Commission adds them to the Union list. The difference matters, because a novel food can become legal overnight when an implementing regulation is published.
NMN
In a consultation answered by the Czech Republic, the Commission published the conclusion: "The ingredient is considered a novel food.", under category 3(2)(a)(i) (consultation result on nicotinamide mononucleotide). The agenda of the Standing Committee section on novel food for 25 September 2026 included a draft implementing regulation "authorising the placing on the market of betanicotinamide mononucleotide (beta-NMN)" (PAFF Committee agenda). Whether that act has been adopted and published, and under what conditions, is to be confirmed on EUR-Lex on the day you plan. Until it is in force, NMN cannot be sold in Poland, and when it is, you must match its specification, maximum level and labelling.
CBD
EFSA said on 7 June 2022 that it "cannot currently establish the safety of cannabidiol (CBD) as a novel food" and put 19 applications on hold (EFSA news). The Spanish food safety agency reported on 12 February 2026 that EFSA had published a provisional update with a level of 0.0275 mg per kg body weight per day, roughly 2 mg of CBD a day for a 70 kg adult, under strict conditions, and that CBD in food, including supplements, remains not permitted until authorised by the Commission (AESAN, our translation). A provisional EFSA level is not an authorisation.
Poland's own list of banned supplement ingredients
Poland adds a national layer. The annex to the Minister of Health Regulation of 13 March 2024 (Dz.U. 2024 poz. 420) is titled "Wykaz substancji innych niż witaminy i składniki mineralne zakazanych w produkcji środków spożywczych", a list of non-vitamin, non-mineral substances banned in food production. GIS confirms that it covers food supplements (GIS, gov.pl).
| No. | Substance (Polish annex wording, English) | Where US brands meet it |
|---|---|---|
| 1 | Yohimbine hydrochloride and the yohimbine group | Fat burners, libido products |
| 2 | DMAA (1,3-dimethylamylamine and listed synonyms) | Pre-workouts |
| 3 | Evodiamine | Thermogenics |
| 4 | SARMs, including andarine (S-4), ligandrol (LGD-4033), ostarine (enobosarm), RAD-140 (testolone) | "Research" sports products |
| 5 | Higenamine | Pre-workouts, fat burners |
| 6 | Hordenine | Pre-workouts, focus blends |
| 7 | Ibutamoren (MK-677) | Sports and "longevity" products |
| 8 | Pancreatin | Digestive enzyme blends |
| 9 | Kava (Piper methysticum) | Relaxation and sleep blends |
| 10 | Velvet bean (Mucuna pruriens) | Dopamine and mood blends |
| 11 | Greater celandine (Chelidonium majus L.), added in 2026 | Liver and digestive herbal blends |
Point 11 was added by the Minister of Health Regulation of 16 March 2026 (Dz.U. 2026 poz. 371). Both acts allow food already on the market before entry into force to stay on sale for no more than 30 days after it. In other words: when Poland adds a substance, you have weeks, not a sell-through year. Check enzyme blends for pancreatin and mood blends for Mucuna in particular.
Is ashwagandha banned in Europe?
Not at EU level on the evidence we could verify. Ashwagandha (Withania somnifera) does not appear in the Polish national list above, including the 2026 amendment. We could not confirm an ashwagandha entry in Annex III from the acts we read, so treat the EU position as to be confirmed against the consolidated Annex III on the day you act.
What official bodies have said is a risk assessment, not a ban. Germany's BfR, in Communication 39/2024 of 10 September 2024, found the data "not sufficient to allow a conclusive risk assessment" and advised that ashwagandha supplements should not be taken by "especially children, pregnant and breastfeeding women and people with acute or pre-existing liver disease" (BfR).
Reports of national bans or planned bans in other Member States circulate in trade media. We have not confirmed them on an official national authority site, so we do not list them here. For a Polish launch: ashwagandha is sellable today, but put risk-group warnings on the label, keep the dose conservative and documented, and watch for EU action. We explain dose practice in Poland in our guide to novel food and maximum doses.
Reformulate, apply or drop: what to do with a flagged ingredient
For each red line in the table, pick one route and write it down. Run this sequence:
- List every ingredient with its exact identity. Latin name, plant part, extract ratio, chemical form, and the additives in the capsule shell and coating. E 171 hides in the coating, not in the active list.
- Run the four checks. Annex III (consolidated), the Union list and novel food status (Commission novel food catalogue), the additives list, and the Polish annex to Dz.U. 2024 poz. 420.
- Remove Part A and Polish-list substances. No dossier fixes these. Replace or drop.
- Recalculate Part B doses per daily portion. Red yeast rice under 3 mg monacolins, EGCG under 800 mg, then add every mandatory warning in Polish.
- Decide on Part C botanicals. Legal today, under review. Keep only if the SKU still works without them.
- Park novel foods. No NMN or CBD in the Polish SKU until an authorisation is in force. Prepare a version that can switch in when it is.
- Lock the Polish specification. Only then brief the manufacturer or set up the import and prepare the GIS notification.
| Route | When it fits | Trade-off |
|---|---|---|
| Reformulate | Part B dose too high, Part C botanical, E 171 coating | New stability and label work; usually the fastest route to shelf |
| Apply | Novel food central to the brand, with a long horizon | Years, data costs, no sales of that ingredient meanwhile |
| Drop | Part A, Polish list, or a minor ingredient | Formula story changes; claims may need rework |
Sources
Primary legal texts and official pages used in this guide. Always read the consolidated version in force on the day you act.
- Regulation (EC) No 1925/2006 on the addition of vitamins, minerals and certain other substances to foods - EUR-Lex
- Commission Regulation (EU) 2015/403 (ephedra) - EUR-Lex
- Commission Regulation (EU) 2019/650 (yohimbe) - EUR-Lex
- Commission Regulation (EU) 2021/468 (hydroxyanthracene derivatives) - EUR-Lex
- Commission Regulation (EU) 2022/860 (monacolins from red yeast rice) - EUR-Lex
- Commission Regulation (EU) 2022/2340 (green tea extracts containing EGCG) - EUR-Lex
- Commission Regulation (EU) 2022/63 (titanium dioxide, E 171) - EUR-Lex
- Regulation (EU) 2015/2283 on novel foods - EUR-Lex
- European Commission - Novel Food status Catalogue
- European Commission - consultation result on nicotinamide mononucleotide (Czech Republic)
- European Commission - PAFF Committee, Section Novel Food and Toxicological Safety, agenda of 25 September 2026
- EFSA - Cannabidiol novel food evaluations on hold pending new data (7 June 2022)
- AESAN (Spanish Agency for Food Safety and Nutrition) - update on the safety of CBD as a novel food (12 February 2026)
- Minister of Health Regulation of 13 March 2024 on fortifying substances added to food (Dz.U. 2024 poz. 420) - ISAP/ELI
- Minister of Health Regulation of 16 March 2026 amending it (Dz.U. 2026 poz. 371) - ELI
- GIS - Substances and plant materials not permitted in food supplements (gov.pl)
- BfR - Ashwagandha: food supplements with potential health risks, Communication 39/2024
This is not legal advice. Annex III, the Union list and national lists change; check the consolidated versions on the day you act and take legal advice for borderline ingredients.